Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 ...
Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances ...
Opaganib | C23H25ClN2O | CID 15604015 - PubChem
Opaganib | CAS 915385-81-8 - AdipoGen Lif Sciences - Selective ...
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In ...
Opaganib hydrochloride (ABC294640 hydrochloride) | SphK Inhibitor ...
Opaganib Protects against Radiation Toxicity: Implications for Homeland ...
The Sphingolipid-Modulating Drug Opaganib Protects against Radiation ...
Opaganib (ABC294640) | SphK Inhibitor | MedChemExpress
Phase 2 trial launches of opaganib plus darolutamide in mCRPC | Urology ...
RedHill Biopharma, Cosmo enter opaganib manufacturing agreement
Opaganib by RedHill Biopharma submitted for approval of investigation ...
Opaganib (ABC294640) | SphK2 抑制剂 | Opaganib (ABC294640)供应商 AdooQ®
Opaganib beschleunigt wohl deutlich Eliminierung von SARS-CoV-2
Opaganib (hydrochloride) | C23H26Cl2N2O | CID 76966934 - PubChem
Enrollment begins in phase 2 trial of opaganib plus darolutamide in mCRPC
PharmaWiki - Opaganib
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kid ...
Opaganib (ABC294640) | CAS 915385-81-8 | AbMole BioScience | Opaganib Price
opaganib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized ...
Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced ...
RedHill Biopharma to expand Covid-19 trial of opaganib to US
Opaganib liefert positive Ergebnisse | PZ – Pharmazeutische Zeitung
RedHill to continue Phase II/III trial of Opaganib for Covid-19
Opaganib plus standard of care for severe COVID-19 reduces mortality
Full article: Recent Progress in the Development of Opaganib for the ...
Opaganib beschleunigt Virus-Clearance | PZ – Pharmazeutische Zeitung
Opaganib – Neues Covid-Medikament weckt Hoffnungen
Opaganib preserves renal function and suppresses inflammation in ...
Inhibition of sphingolipid metabolism by opaganib. Opaganib (also known ...
(PDF) Compassionate Use of Opaganib for Patients with Severe COVID-19
Multitargeting of sphingolipid metabolism by opaganib. Opaganib (aka ...
Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obe ...
Single-dose opaganib improves survival of partially shielded irradiated ...
Opaganib Helps Treat Moderate-to-severe COVID-19
Opaganib protects against lethality from total body irradiation. Mice ...
Opaganib improves renal function after moderate ischemia-reperfusion ...
Model for antitumor activity of opaganib. Opaganib acts as a ...
Full article: The Sphingosine Kinase 2 Inhibitor Opaganib Protects ...
RedHill's COVID-19 candidate Opaganib reduces ARDS-related blood ...
Opaganib (ABC294640) | SphK2 Inhibitor | CAS 915385-81-8 | Selleck ...
Opaganib hydrochloride (ABC294640) | SphK2 inhibitor | Probechem ...
Opaganib ABC294640 Anti-Inflammatory and Anti-Viral Tablets
Opaganib-d15 | C23H25ClN2O | CID 169444936 - PubChem
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor ...
Opaganib, el nuevo tratamiento israelí contra el Covid-19 fue exitoso ...
RedHill Releases ‘Positive’ Results From Early Covid-19 Trial With ...
Organometallic small molecule kinase inhibitors – direct incorporation ...
Drugs for COVID-19: An Update
Phase I study of opaganib, an oral sphingosine kinase 2-specific ...
58 Covid19 Drug Candidate Royalty-Free Photos and Stock Images ...
Opaganib(Opaganib) - 药物靶点：SPHK2_在研适应症：流感病毒感染，转移性去势抵抗性前列腺癌，胆管癌_专利_临床_研发
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data ...
Covid-19 - Produktionskapazitäten für Notfallmedikament werden ausgebaut
RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study ...
| DDDT | Dove Medical Press
Opaganib, el fármaco de RedHill para la COVID-19 que se encuentra en ...
L'israélien RedHill espère que son médicament change la donne contre la ...
.: RedHill Biopharma Anuncia la Presentación de Datos Positivos de Fase ...
